Abstract
The aim of the present study was to evaluate various functional tests for the differentiation of hyperinsulinaemic hypoglycaemia. The pathophysiological and histological findings in six infants, aged 2–7 months, with persistent hyperinsulinaemic hypoglycaemia are described. Islet cell adenoma was found in four infants and pancreatic nesidioblastosis in two others. Circulating levels of blood glucose (BG), immunoreactive insulin and C-peptide immunoreactivity were measured under basal conditions and during both stimulation and suppression. The diagnosis of hyperinsulinaemia was made by estimation of the BG/serum insulin ratio, which was the most important diagnostic criterion of hyperinsulinism. Control subjects of comparable age showed a ratio of 8.3±4.4 (range 4.1–13.3), whereas the six patients had values between 0.3 and 5.1. At least four determinations with ratios lower than 2.6 were necessary for confirming the diagnosis. Preoperatively we performed oral glucose tolerance, diazoxide infusion, somatostatin infusion and C-peptide suppression tests. It is suggested that the various function tests, especially the suppression tests, do not differentiate hyperinsulinism caused by an adenoma from that caused by diffuse pancreatic nesidioblastosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- IRI:
-
Immunoreactive insulin
- BG:
-
blood glucose
- CPR:
-
C-peptide immunoreactivity
- HCP:
-
human C-peptide
- BW:
-
body weight
References
Aynsley-Green A (1981) Nesidioblastosis of the pancreas in infancy. In: Randle PI, Steiner DF, Whelan WI (eds) Carbohydrate metabolism and its disorders. Academic Press, New York, pp 181–204
Besch W, Kohnert KD, Lorenz D, Hahn HJ, Ziegler M (1984) A rapid radioimmunoassay for insulin suitable for testing pancreatic tissue prior to transplantation. Clin Chim Acta 142:249–255
Beyer JU, Cordes U, Günther R, Georgi M, Thelen M, Kümmerle F, Happ J, Krause U (1982) Lokalisationsdiagnostik bei Insulinomen. Dtsch Med Wochenschr 107:205–208
Colturi TJ, Unger RH, Feldman M (1984) Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release and islet cell function. J Clin Invest 74:417–423
Copinsci G, Leclerq-Mayer V, Virasoro E (1976) Pituitary and extrapituitary effects of somatostatin in normal man. Horm Metab Res 8:226–231
Fajans SS, Vinik AI (1984) Diagnosis and treatment of insulinoma. In: Santen RJ, Manni A (eds) Diagnosis and management of endocrine-related tumors. Nijhoff, Boston, pp 112–135
Glaser B, Valtysson G, Fajans SS, Vinik AI, Cho K, Thompson N (1981) gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism. Metabolism 30:1001–1010
Goudsward WB, Zwiestra RP, Houthoff HJ, Rouwe C, Koostra G (1984) Surgical treatment of organic hyperinsulinism in infancy. Z Kinderchir 39:91–95
Harrop JS, Golding PR, Goodalli P, Levenux VM, Steele GA, Ingle AR (1982) C-peptide suppression test and sulphonylure-induced factitious hypoglycemia. Br Med J 284:940–941
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541–548
Heitz PU, Klöppel G, Häcki WH, Polak JM, Pearse AGE (1977) The pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Diabetes 26:632–642
Henquin JC, Charles S, Henquin M, Mathot F, Tamagawa T (1982) Diazoxide and D 600 inhibition of insulin release. Diabetes 31:776–783
Jaffe R, Hashida Y, Yunis EJ (1980) Pancreatic pathology in hyperinsulinemic hypoglycemia in infancy. Lab Invest 42:356–365
Kunz J, Amendt P, Buntrock P, Gottschalk J, Hahn V, Dorsche H (1986) Pancreatic endocrine tumors: histological, immunocytochemical and electronmicroscopical investigations. Acta Histochem [Suppl] 33:233–241
Mandelkow H, Goetz K, Kühnau J (1981) C-Peptid Suppressionstest bei Normalen und Insulinomträgern. Versuch einer funktionsdiagnostischen Bewertung. Klin Wochenschr 59:1209–1215
Martin LW, Ryckman RC, Sheldon CA (1984) Experience with 95% pancreatectomy and splenic salvage for neonatal nesidioblastosis. Ann Surg 200:355–362
Rahier J, Wallowand J, Henquin J (1980) Abundance of somatostatin cells in the human neonatal pancreas. Diabetologia 18:251–254
Roti E, Ghinelli C, Bandini P, Del Rossi C, Emanuele R, Robuschi G (1981) Effects of somatostatin in a case of severe hypoglycemia due to nesidioblastosis. J Endocrinol Invest 4:209–212
Scuro LA, Cascio V, Adami S, Galvanini G, Bianchi I, Cominancini L, Corgnati A (1976) Somatostatin inhibition of insulin secretion in insulin producing tumors. Metabolism 25:603–609
Soltesz G, Aynsley-Green A (1984) Hyperinsulinism in infancy and childhood. In: Frick P, Harnack GA v, Kochsiek K, Martini GA, Prader A (eds) Advances in internal medicine and pediatrics. Springer, Berlin Heidelberg New York, pp 151–202
Villaume C, Beck B, Dollet JM, Pointel JP, Derby G (1984) 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas. Ann Endocrinol 45:155–160
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amendt, P., Kohnert, K.D. & Kunz, J. The hyperinsulinaemic hypoglycaemias in infancy: a study of six cases. Eur J Pediatr 148, 107–112 (1988). https://doi.org/10.1007/BF00445914
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00445914